Lunaphore Technologies takes in Series C

Lunaphore Technologies SA, a Swiss developer of equipment for cancer research and tissue diagnostics, has raised CHF 23 million in Series C funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this